Lara S. Kallander
Publications by Year
Research Areas
Career Development and Diversity, Mentoring and Academic Development, Diversity and Career in Medicine, Signaling Pathways in Disease, Peptidase Inhibition and Analysis
Most-Cited Works
- → 4-Aryl-1,2,3-triazole: A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo(2005)188 cited
- → Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart(2013)70 cited
- → A Versatile Enantioselective Strategy Towardl-C-Nucleosides: A Total Synthesis ofl-Showdomycin(1999)62 cited
- → Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)(2015)46 cited
- → Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists(2005)33 cited
- → 4,6-Diaminopyrimidines as Highly Preferred Troponin I-Interacting Kinase (TNNI3K) Inhibitors(2018)25 cited
- → Substituent Effects on Drug–Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors(2016)23 cited
- → Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1(2018)21 cited
- → GSK114: A selective inhibitor for elucidating the biological role of TNNI3K(2016)17 cited
- → Quantitative Structure−Activity Relationships of 2,4-Diamino-5-(2-X-benzyl)pyrimidines versus Bacterial and Avian Dihydrofolate Reductase(1998)17 cited